肝细胞癌
医学
肝硬化
内科学
乙型肝炎病毒
胃肠病学
HBeAg
慢性肝炎
相对风险
基因型
乙型肝炎
肝癌
风险因素
病毒
免疫学
乙型肝炎表面抗原
置信区间
基因
生物
遗传学
作者
Man‐Fung Yuen,Yasuhito Tanaka,Dyt Fong,James Fung,Danny Ka‐Ho Wong,John Chi–Hang Yuen,David Yiu‐Kuen But,Annie On‐On Chan,Benjamin Chun‐Yu Wong,Masashi Mizokami,Ching‐Lung Lai
标识
DOI:10.1016/j.jhep.2008.07.023
摘要
To determine whether gender, age, hepatitis B virus genotype, core promoter and precore mutations, HBeAg/ anti-HBe status, HBV DNA, ALT levels and cirrhosis on presentation were independent risk factors and derive a novel risk score for the development of HCC.CHB patients (820) were followed up (mean duration 76.8 months) for the occurrence of HCC.The 5- and 10-year prevalence of HCC were 4.4% and 6.3%, respectively. Cox regression analysis showed that male gender (p = 0.025, RR 2.98), increasing age (p < 0.001, RR 1.07), higher HBV DNA levels (p = 0.02, RR 1.28), core promoter mutations (p = 0.007, RR 3.66), and presence of cirrhosis (p < 0.001, RR 7.31) were independent risks for the development of HCC. A risk score was derived and validated with sensitivity > 84% and specificity > 76% to predict the 5- and 10- year risks for the development of HCC. The AUC for the 5- and 10-year prediction were 0.88 and 0.89, respectively.The risk score, based on age, gender, HBV DNA levels, core promoter mutations and cirrhosis, can estimate the chance of development of HCC in 5 and 10 years after presentation. It can be used to identify high-risk CHB patients for treatment and screening of HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI